Patents by Inventor Willard Foss

Willard Foss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230243806
    Abstract: The present invention provides methods of assessing suitability of a pharmaceutical composition for medical use. The pharmaceutical composition comprises nanoparticles comprising rapamycin coated with albumin and a non-nanoparticle portion comprising albumin and rapamycin.
    Type: Application
    Filed: September 27, 2022
    Publication date: August 3, 2023
    Applicant: Abraxis BioScience, LLC
    Inventors: Viktor PEYKOV, Willard FOSS, Daniel W. PIERCE, Neil P. DESAI
  • Patent number: 11320416
    Abstract: The present invention provides methods of assessing suitability of a pharmaceutical composition for medical use. The pharmaceutical composition comprises nanoparticles comprising rapamycin coated with albumin and a non-nanoparticle portion comprising albumin and rapamycin.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: May 3, 2022
    Assignee: Abraxis BioScience, LLC
    Inventors: Viktor Peykov, Willard Foss, Daniel W. Pierce, Neil P. Desai
  • Patent number: 10900951
    Abstract: The present invention provides methods of assessing suitability of a pharmaceutical composition for medical use. The pharmaceutical composition comprises nanoparticles comprising paclitaxel coated with albumin and a non-nanoparticle portion comprising albumin and paclitaxel.
    Type: Grant
    Filed: July 22, 2019
    Date of Patent: January 26, 2021
    Assignee: Abraxis BioScience, LLC
    Inventors: Viktor Peykov, Willard Foss, Daniel W. Pierce, Neil P. Desai
  • Publication number: 20200407681
    Abstract: Provided herein are methods in the field of cell culture, specifically of culture and expansion of immune cells, e.g., T lymphocytes.
    Type: Application
    Filed: April 15, 2020
    Publication date: December 31, 2020
    Applicant: CELGENE CORPORATION
    Inventors: Stewart Abbot, Willard Foss, Thomas Daniel
  • Patent number: 10705070
    Abstract: The present invention provides methods of assessing suitability of a pharmaceutical composition for medical use. The pharmaceutical composition comprises nanoparticles comprising rapamycin coated with albumin and a non-nanoparticle portion comprising albumin and rapamycin.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: July 7, 2020
    Assignee: Abraxis BioScience, LLC
    Inventors: Viktor Peykov, Willard Foss, Daniel W. Pierce, Neil P. Desai
  • Publication number: 20200206212
    Abstract: Provided herein are formulations and methods of use of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide or a stereoisomer or mixture of stereoisomers, pharmaceutically acceptable salt, tautomer, prodrug, isotopologue, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.
    Type: Application
    Filed: December 30, 2019
    Publication date: July 2, 2020
    Inventors: Rowena Fernandez Choudrie, Willard Foss, Che-Hsiung Hsu, Amol Mungikar, Yu Pu
  • Patent number: 10555912
    Abstract: Provided herein are use of polymeric excipients, specifically polyvinyl alcohols, optionally in conjunction with sugars, as cryoprotectants to prevent aggregation of PEG-containing particles. Also provided are PEG-containing particles comprising such polymeric excipients.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: February 11, 2020
    Assignee: Abraxis BioScience, LLC
    Inventors: Willard Foss, Rajesh Shinde
  • Patent number: 10527604
    Abstract: The present invention provides methods of assessing suitability of a pharmaceutical composition for medical use. The pharmaceutical composition comprises nanoparticles comprising paclitaxel coated with albumin and a non-nanoparticle portion comprising albumin and paclitaxel.
    Type: Grant
    Filed: March 5, 2016
    Date of Patent: January 7, 2020
    Assignee: ABRAXIS BIOSCIENCE, LLC
    Inventors: Viktor Peykov, Willard Foss, Daniel W. Pierce, Neil P. Desai
  • Publication number: 20190247357
    Abstract: The present invention provides compositions comprising nanoparticles comprising (a) a hydrophobic drug, (b) an albumin, and (c) a bioactive polypeptide. The present invention also provides method of making compositions comprising nanoparticles comprising (a) a hydrophobic drug, (b) an albumin, and (c) a bioactive polypeptide. Further provided are methods of use, pharmaceutical compositions, medicines, and kits thereof.
    Type: Application
    Filed: October 10, 2017
    Publication date: August 15, 2019
    Inventors: Willard FOSS, Viktor PEYKOV
  • Publication number: 20190054033
    Abstract: Provided herein are use of polymeric excipients, specifically polyvinyl alcohols, optionally in conjunction with sugars, as cryoprotectants to prevent aggregation of PEG-containing particles. Also provided are PEG-containing particles comprising such polymeric excipients.
    Type: Application
    Filed: August 21, 2018
    Publication date: February 21, 2019
    Inventors: Willard FOSS, Rajesh SHINDE
  • Patent number: 10076501
    Abstract: Provided herein are use of polymeric excipients, specifically polyvinyl alcohols, optionally in conjunction with sugars, as cryoprotectants to prevent aggregation of PEG-containing particles. Also provided are PEG-containing particles comprising such polymeric excipients.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: September 18, 2018
    Assignee: Abraxis BioScience, LLC
    Inventors: Willard Foss, Rajesh Shinde
  • Publication number: 20170224627
    Abstract: Provided herein are use of polymeric excipients, specifically polyvinyl alcohols, optionally in conjunction with sugars, as cryoprotectants to prevent aggregation of PEG-containing particles. Also provided are PEG-containing particles comprising such polymeric excipients.
    Type: Application
    Filed: January 23, 2017
    Publication date: August 10, 2017
    Inventors: Willard FOSS, Rajesh SHINDE
  • Patent number: 9585960
    Abstract: Provided herein are use of polymeric excipients, specifically polyvinyl alcohols, optionally in conjunction with sugars, as cryoprotectants to prevent aggregation of PEG-containing particles. Also provided are PEG-containing particles comprising such polymeric excipients.
    Type: Grant
    Filed: December 13, 2012
    Date of Patent: March 7, 2017
    Assignee: ABRAXIS BIOSCIENCE, LLC
    Inventors: Willard Foss, Rajesh Shinde
  • Publication number: 20160137980
    Abstract: Provided herein are methods in the field of cell culture, specifically of culture and expansion of immune cells, e.g., T lymphocytes.
    Type: Application
    Filed: June 23, 2014
    Publication date: May 19, 2016
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, Willard Foss, Thomas Daniel
  • Publication number: 20150157722
    Abstract: Provided herein are use of polymeric excipients, specifically polyvinyl alcohols, optionally in conjunction with sugars, as cryoprotectants to prevent aggregation of PEG-containing particles. Also provided are PEG-containing particles comprising such polymeric excipients.
    Type: Application
    Filed: December 13, 2012
    Publication date: June 11, 2015
    Applicant: ABRAXIS BIOSCIENCE, LLC
    Inventors: Willard Foss, Rajesh Shinde